Battlefield Syphilis: The disease that refuses to die
This activity will present the opportunities and lifesaving options available through testing and updated treatments. Preventing mortality in children and adults is possible with increased awareness and a plan to strike early. The use of penicillin will be examined.
1. Examine the clinical manifestations of syphilis
2. Outline effective ways to accurately diagnose syphilis
3. List effective treatment options for syphilis
|Helpful Tips for Users - Vizient CE System.docx||79.2 KB|
|11-21-2022 - CE Information for Credit - Live_2022.docx||127.3 KB|
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Absence of Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
No one in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.
Nathan Price, MD
Associate Professor of Pediatrics
Division of Pediatric Infectious Diseases
Medical Director of Pediatric Infection Prevention and Antimicrobial Stewardship
University of Arizona
Banner Medical Center-Tucson
Jackie Stokes, BS
Manager, Pharmacy Program
John Schoen, PharmD, BCPS
Sr Clinical Manger, Drug Information
Joseph M. Geskey, DO, MBA, MS-PopH
Principal, Data Science & Member Insights
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-22-156-L01-P
Vizient, Inc. designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation indicating the maximum credits available. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
- 1.00 ACPE Pharmacist
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General CE – Attendance